FDA’s COVID-19 Product Regulation Enforcement Roadmap
By EsqSocial Corporation 30/12/20
Navigating FDA’s regulatory enforcement strategies is paramount to successfully marketing health and medical products for COVID‑19—especially since the pandemic has dominated FDA’s enforcement activity this year. Understanding the patterns and principles behind FDA’s efforts can provide the insight product manufacturers need to avoid FDA enforcement and let companies know what to expect if they do become the target of enforcement action......
By: Morrison & Foerster LLP - Class Dismissed